Optimizing Comprehensive Genomic Profiling and NTRK Fusion Detection in Advanced Cancers
sponsored by Illumina
1 December 2021 / 11:00 am CET
This virtual interactive case-based expert forum will be discussing NTRK fusion detection and therapeutic management of NTRK fusion driven advanced cancers. Real world application of testing modalities assessing the spectrum of genomic alterations in oncology care today including comprehensive genomic profiling, differentiating attributes of DNA and RNA workflows and testing chemistries will be reviewed in addition to the discussion of specific NTRK fusion positive Illumina cases.
- Provide an overview of the clinical value of comprehensive genomic profiling in cancer pathology
- Discuss real world application of testing modalities for NTRK fusion detection
- Discuss the testing and management of patient cases in NSCLC, Thyroid Cancer, and Sarcoma